Researchers performed population-based prospective cohort study at two university hospitals in Denmark. They screened all patients for toxigenic C. difficile in the intestine upon admission, from Oct. 1, 2012, to Jan. 31, 2013.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The C. diff infection was detected in 2.6 percent of patients not exposed to carriers and in 4.6 percent of patients exposed to carriers who showed no symptoms. The amount of exposure correlated with risk of C. diff infection — from 2.2 percent infected in the lowest quartile of exposed patients to 4.2 percent in the highest quartile.
More articles on healthcare quality:
Joe Biden criticizes the White House’s proposed NIH cuts
Common antibiotic displays efficacy in treatment of PTSD
CDC releases free guide to pharmacists’ role in preventing falls
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
